share

1,4-Dihydro-6-(Trifluoromethyl)Quinoxaline-2,3-Dione CAS NO 55687-31-5


Unit Price:

CAS No.:55687-31-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

1,4-Dihydro-6-(Trifluoromethyl)Quinoxaline-2,3-Dione is a specialized heterocyclic organic compound featuring a quinoxaline-2,3-dione core substituted with a trifluoromethyl group. This molecular structure makes it a valuable pharmacological research intermediate, particularly in the development of compounds targeting the central nervous system. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in synthesizing novel therapeutic agents and advanced materials.

Application

  • Key Intermediate in Pharmaceutical Research: Serves as a critical building block for synthesizing potential neuroprotective agents and glutamate receptor modulators.
  • Neurological Disorder Studies: Used in preclinical research for developing compounds targeting conditions like stroke, epilepsy, and neurodegenerative diseases.
  • Medicinal Chemistry: Employed in structure-activity relationship (SAR) studies to optimize drug candidate profiles.
  • Biochemical Research: Acts as a tool compound in studying ion channel and receptor functions within biological systems.
  • Fine Chemical Synthesis: Utilized in the production of complex, high-value specialty chemicals for advanced applications.
  • Agrochemical Research: Investigated as a precursor for novel active ingredients with specific biological activity.

Basic Information

Product Name 1,4-Dihydro-6-(Trifluoromethyl)Quinoxaline-2,3-Dione
CAS No. 55687-31-5
Molecular Formula C9H5F3N2O2
Molecular Weight 230.15 g/mol
Synonyms 6-(Trifluoromethyl)-1,4-dihydroquinoxaline-2,3-dione; 6-Trifluoromethyl-1,4-dihydroquinoxaline-2,3-dione; 1H-Quinoxaline-2,3-dione, 1,4-dihydro-6-(trifluoromethyl)-; 6-Trifluoromethylquinoxaline-2,3(1H,4H)-dione; TFDQ; TFQ; DNQX derivative (structural analog)
EINECS Contact for details

Quality Control

Our 1,4-Dihydro-6-(Trifluoromethyl)Quinoxaline-2,3-Dione is produced under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with every shipment, confirming compliance with agreed specifications. We support cGMP standards for materials intended for research use in regulated environments.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. The compound is light-sensitive (store away from light).

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.